| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 590.238 | 1.423.984 | 1.166.507 |
| Total Income - EUR | - | - | - | - | - | - | - | 590.238 | 1.424.049 | 1.166.521 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 499.313 | 1.189.234 | 1.124.456 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 90.924 | 234.815 | 42.065 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 85.202 | 202.880 | 35.517 |
| Employees | - | - | - | - | - | - | - | 8 | 9 | 6 |
Check the financial reports for the company - Ygeia Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 1.264 | 11.132 | 117.170 |
| Current Assets | - | - | - | - | - | - | - | 225.541 | 377.769 | 325.589 |
| Inventories | - | - | - | - | - | - | - | 12.860 | 24.103 | 14.786 |
| Receivables | - | - | - | - | - | - | - | 193.799 | 87.265 | 185.923 |
| Cash | - | - | - | - | - | - | - | 18.881 | 266.401 | 124.879 |
| Shareholders Funds | - | - | - | - | - | - | - | 85.242 | 287.864 | 221.255 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 141.563 | 101.117 | 221.503 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8691 - 8691" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Ygeia Medical S.r.l.